OR WAIT null SECS
Mathini Ilancheran is a Senior Research Analyst, with Beroe Inc, Chennai, India
January 29, 2015
The developed markets of North America and Europe together saw approximately 81% of the Phase I trial share in 2013 which is a 6% increase from 2012. Trials